These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6693772)

  • 1. Cytolysis of nucleated cells by complement: inhibition of membrane-transmethylation enhances cell death by C5b-9.
    Hänsch GM; Betz M; Shin ML
    J Immunol; 1984 Mar; 132(3):1440-4. PubMed ID: 6693772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleated cell killing by complement: effects of C5b-9 channel size and extracellular Ca2+ on the lytic process.
    Kim SH; Carney DF; Hammer CH; Shin ML
    J Immunol; 1987 Mar; 138(5):1530-6. PubMed ID: 2433349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9.
    Carney DF; Koski CL; Shin ML
    J Immunol; 1985 Mar; 134(3):1804-9. PubMed ID: 3968432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense.
    Ohanian SH; Schlager SI
    Crit Rev Immunol; 1981 Jan; 1(3):165-209. PubMed ID: 6174273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement-mediated inhibition of function in complement-resistant Escherichia coli.
    Dankert JR
    J Immunol; 1989 Mar; 142(5):1591-5. PubMed ID: 2645364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of membrane lipid metabolism enhance complement-mediated nucleated cell killing through distinct mechanisms.
    Papadimitriou JC; Carney DF; Shin ML
    Mol Immunol; 1991 Aug; 28(8):803-9. PubMed ID: 1875952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma membrane and intracellular lipid synthesis in tumor cells rendered resistant to humoral immune killing after treatment with hormones.
    Schlager SI; Ohanian SH
    J Natl Cancer Inst; 1980 Apr; 64(4):943-50. PubMed ID: 6988626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The deposition of C5b-9 complexes and its precursors on E. coli J5 during complement activation enhances uptake and toxicities of gentamicin.
    Bloch EF; Morrison K; McDonald-Pinkett S; Baskin S; Campbell S; Peters S; Dillahunt S; Evans D; Lucas S; Macatangay A; Kanaan Y
    Immunol Invest; 2008; 37(3):245-61. PubMed ID: 18389443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublytic complement attack exposes C-reactive protein binding sites on cell membranes.
    Li YP; Mold C; Du Clos TW
    J Immunol; 1994 Mar; 152(6):2995-3005. PubMed ID: 8144898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.
    Gancz D; Donin N; Fishelson Z
    Mol Immunol; 2009 Dec; 47(2-3):310-7. PubMed ID: 19864026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulators and the complement system.
    Kondo M; Kato H; Yoshikawa T; Sugino S
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):67-72. PubMed ID: 3713376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement. Historical perspectives and some current issues.
    Mayer MM
    Complement; 1984; 1(1):2-26. PubMed ID: 6100484
    [No Abstract]   [Full Text] [Related]  

  • 14. Beyond lysis: how complement influences cell fate.
    Cole DS; Morgan BP
    Clin Sci (Lond); 2003 May; 104(5):455-66. PubMed ID: 12580763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complement and biological membrane].
    Takahashi M
    Nihon Rinsho; 1979; 37(7):2782-91. PubMed ID: 393861
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of enhanced complement-dependent cytotoxicity of papain-treated lymphocytes: evidence for increased stability of classical pathway C3 convertase.
    Lublin DM; Grumet FC
    J Immunol; 1982 Feb; 128(2):866-70. PubMed ID: 6915075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps.
    Ollert MW; Kadlec JV; David K; Petrella EC; Bredehorst R; Vogel CW
    J Immunol; 1994 Sep; 153(5):2213-21. PubMed ID: 8051421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubilization of antigen-antibody complexes: a new function of complement as a regulator of immune reactions.
    Takahashi M; Takahashi S; Hirose S
    Prog Allergy; 1980; 27():134-66. PubMed ID: 6986046
    [No Abstract]   [Full Text] [Related]  

  • 19. A reexamination of the role of clusterin as a complement regulator.
    Hochgrebe TT; Humphreys D; Wilson MR; Easterbrook-Smith SB
    Exp Cell Res; 1999 May; 249(1):13-21. PubMed ID: 10328949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective lysis of early embryonic cells by the alternative pathway of complement--a possible mechanism for programmed cell death in embryogenesis.
    Kircheis R; Kircheis L; Oshima H; Kohchi C; Soma G; Mizuno D
    In Vivo; 1996; 10(4):389-403. PubMed ID: 8839785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.